JOHN FRIEDMAN
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
DIRECTOR
JAMES BRODERICK,
GEOFF DILLON,
STOTE ELLSWORTH,
MARKUS GOEBEL,
LARRY KAUVAR,
LAWRENCE KAUVAR,
LAWRENCE M. KAUVAR,
THOMAS LAVIN,
GERALD MCMAHON,
NORA MENDE,
STEFAN RYSER,
SOMU SUBRAMANIAM,
ELISABETH WHITNEY
DIRECTOR
LEO EINCK,
GARY HORWITH,
WILLIAM HOSKINS,
ALAN KLEIN,
KENNETH LYNN,
PAIGE MACDONALD,
DAVID MCNEELEY,
RONALD I MELTZER,
RONALD I. MELTZER,
LAWRENCE MILLER,
CAROL A NACY,
CAROL A. NACY,
MARK RAMPY,
BRADLEY ROTTER,
MARTIN M ZUG
DIRECTOR
KEN ARNOLD,
JOHN GUO,
PETER HADROVIC,
TRISTEN LANGLEY,
GERALD MITCHELL,
RICHARD NASH,
MARC RUSSO,
JOHN SCULL,
PETER SCULL,
WILLEM VOLSCHENK,
JOHNATHAN WHITEHOUSE
DIRECTOR
JAMES BRODERICK,
GEOFF DILLON,
STOTE ELLSWORTH,
MARKUS GOEBEL,
LARRY KAUVAR,
LAWRENCE KAUVAR,
LAWRENCE M. KAUVAR,
THOMAS LAVIN,
GERALD MCMAHON,
NORA MENDE,
STEFAN RYSER,
SOMU SUBRAMANIAM,
ELISABETH WHITNEY
DIRECTOR
JAMES W BRODERICK,
JAMES W. BRODERICK,
JAMES W. BRODERICK, M.D.,
DOMINICK C COLANGELO,
DOMINICK C. COLANGELO,
JOHN H. FRIEDMAN,
PAUL D GOLDENHEIM,
PAUL D. GOLDENHEIM,
PAUL D. GOLDENHEIM, M.D.,
LARRY KAUVAR,
MARK LUPHER,
GEERT-JAN MULDER,
AMIR NASHAT,
HANNS A. PIELENZ,
HAROLD R WERNER,
HAROLD R. WERNER,
JOSEPH ZAKRZEWSKI,
JOSEPH S. ZAKRZEWSKI
DIRECTOR
GRACE COLON,
ROBERT E. CURRY,
ALAN JACOBS,
JENNIFER JACOBS,
TOM KING,
THOMAS LAVIN,
FRANK MAIONE,
RODNEY MARKIN,
HAMUTAL RUSSO,
ROBERT SCHUEREN,
SOMU SUBRAMANIAM,
JAMES WOODY
DIRECTOR
LEO EINCK,
GARY HORWITH,
WILLIAM HOSKINS,
ALAN KLEIN,
KENNETH LYNN,
PAIGE MACDONALD,
DAVID MCNEELEY,
RONALD I MELTZER,
RONALD I. MELTZER,
LAWRENCE MILLER,
CAROL A NACY,
CAROL A. NACY,
MARK RAMPY,
BRADLEY ROTTER,
MARTIN M ZUG
DIRECTOR
ROBERT CRUTCHFIELD,
N/A GOOD LIFE SCIENCES GENERATIONS FUND I GP LLC,
DAVID MENDEZ,
CATHERINE MOHR, MD,
LAWRENCE OLANOFF, MD, PHD,
AMY SALZHAUER,
LONNY YARMUS, DO, MBA, PHD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
VENTURE CAPITAL FUND
DECLINE TO DISCLOSE
2026-05-18
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2025-10-01
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2024-12-05
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2023-07-11
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2021-07-30
D
OTHER
DECLINE TO DISCLOSE
2019-09-11
D
OTHER
DECLINE TO DISCLOSE
2020-11-09
D
OTHER
DECLINE TO DISCLOSE
Equity
2018-05-07
D
OTHER
DECLINE TO DISCLOSE
Equity
2018-04-06
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2017-09-07
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2016-08-03
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2016-08-03
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Debt
2015-10-16
D/A
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2014-09-10
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2014-09-26
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2014-09-10
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2014-01-22
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2013-10-01
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2013-08-28
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2013-09-06
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2012-11-19
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-08-22
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2008-12-09
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2010-03-19
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2012-02-21
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2011-10-27
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2011-10-19
D/A
OTHER
DECLINE TO DISCLOSE
Debt
2011-07-08
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2011-08-01
D/A
OTHER
DECLINE TO DISCLOSE
Debt
2011-07-08
D
OTHER
DECLINE TO DISCLOSE
Debt
2011-07-08
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2011-05-13
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2010-11-17
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2010-11-17
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2010-10-08
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2010-07-07
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2010-06-30
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2010-02-19
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2009-07-08
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2009-07-08
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2009-06-12
